Reliance Life Sciences is a diverse and integrated biotechnology initiative of the Reliance Group of companies. The Reliance Group is India’s largest private sector enterprise, with annual revenues of US$ 66.8 billion. The Group’s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing and telecom. The Group’s flagship company Reliance Industries Limited is the largest private sector company and a Fortune Global 500 company. Reliance Life Sciences is part of the Promoter Group of Reliance Industries Limited. RLS was established to develop business opportunities in medical biotechnology with key initiatives in biopharmaceuticals, pharmaceuticals, regenerative medicine, clinical research and molecular diagnostics.

Accelerated Biosciences Corp. is a private company headquartered in the United States that provides regenerative medicine company.

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases. Its product includes NiCord, a cell therapy based on NAM-expanded cord blood developed to improve and extend the life-saving benefits of hematopoietic stem cell transplant. The company applies an expansion platform supporting the properties of NAM to allogeneic cell sources that include omidubicel, an investigational product with potential as a life-saving alternative for patients in need of bone marrow transplant.

Boston Biomedical Research Institute (BBRI) was a non-profit institution concentrating on basic biomedical research to promote the understanding of human diseases (including heart disease, cancer, muscular dystrophy and Alzheimer's etc.). It was located in Watertown, Massachusetts.

Accurate International is engaged in the research and development of regenerative medicines based on the four centers of organoid tissue and disease models. clinical medicine transformation, big data sharing, and smart device development.

Founded by world leaders in the field of regenerative medicine, ProChon is a privately-held biotechnology company focused on modulating the fibroblast growth factor system to enable it to create more effective solutions for tissue regeneration. ProChon's products combine cell regeneration technologies with proprietary growth factors and biocompatible scaffolds to restore injured or chronically damaged tissues to normal. ProChon has filed patent applications, licensed patents for core technologies and products, and has been granted patents in the United States, Europe, Israel and Australia. ProChon's R&D facility resides in Ness Ziona, Israel and the executive management team is based in Woburn, Massachusetts.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Akita Prefectural University (秋田県立大学 Akita kenritsu daigaku) is a Japanese prefectural university, located in Akita City, Japan.

Beijing Jizhongke Biotechnology Co., Ltd., established on 2018-02-02, Business scope includes biotechnology,Technology development of stem cells and immune cells,Technical Services,technical consulting,technology transfer,Technical testing;Import and export,Technology Import and Export,Agent import and export;Medical Research and Experimental Development;Natural Science and Experimental Development;Sales Class I,Class II medical device,electronic product,Equipment;retail medicine.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Retail pharmaceuticals and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Beijing Chengnuo Medical Technology Co., Ltd., established on 2010-09-16, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Medical Research and Experimental Development;Sales of medical devices Class I;Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Tianjin Exosome Technology Co., Ltd., established on 2021-07-02, Business scope includes medical research and experimental development;Cell technology research and application;Engineering and Technology Research and Experimental Development;Natural science research and experimental development;New material technology research and development;New material technology promotion service;pharmaceutical production;Human stem cell technology development and application;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology intermediary service;Import and export;Drug import and export;Technology Import and Export;Production of Class I Medical Devices;Production of Class II Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiutian Biopharmaceutical (Shanghai) Co., Ltd. is a Chinese company located in Shanghai, with subsidiaries in the United States and the Cayman Islands. The firm operates as a biotechnology company. It was founded in 2019.

Chongqing Paijin Biotechnology Co., Ltd., established on 2013-03-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Biochemical product technology research and development,Fermentation process optimization technology research and development,Engineering and Technology Research and Experimental Development,Medical Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.